Category: FDA & Regulatory Policy (Page 8)

November 14, 2011

FDA Under Fire

Last month, the FDA published a long awaited report on biomedical innovation, their only course of defense in the recent onslaught against the agency. Historically, the FDA has played a significant role in the protection of our health, assuming sole responsibility for the approval of medical products, but it appears that congressional confidence in the agency is waning.
June 30, 2011

PDUFA V Can Help Patients and the FDA

On June 26, 2011 I was interviewed by BioCentury This Week to share the Alliance for Aging Research’s impressions on the fifth reauthorization of the Food and Drug Administration’s Prescription Drug User Fee program. Thanks to Congress, we and other active patient groups were able to lend an early voice in helping to shape how user fees might be used to help speed the delivery of better treatments and cures to patient in need of relief from Alzheimer’s, Cancer, Parkinson’s and many more diseases.  
June 8, 2011

Advocates: FDA deal with drug makers “opaque”

Consumer advocates are blasting the FDA for the process it has used to renegotiate the terms of the drug approval process following news that a deal has been reached with industry on proposed changes to the process.
April 1, 2010

Alliance President Makes Remarks at a Hearing on Prescription Drug User Fee Act Reauthorization

On April 12th, Alliance President & CEO Daniel Perry presented remarks at a public meeting on the reauthorization process for…
January 28, 2009

A “Pro-Cures” FDA

One week into the Obama Administration and the choice of a new Commissioner of the Food and Drug Administration may be only days away. This is a critical moment for anyone who will face a life-threatening or life-shortening disease or disability. Aging Baby Boomers take note: in time, if not right now, the FDA choice will affect you directly and personally.
March 18, 2008

FDA Needs More Funding to Fulfill Its Mission

On February 4, 2008, the Bush administration released its proposed budget recommendations for funding all federal agencies in fiscal year 2009. Under this proposal, the U.S. Food and Drug Administration would receive a 2.9% overall increase in funding this year.
July 17, 2007

Alliance Commends Senate Committee for Increase in FDA Funding

The Alliance for Aging Research today commends the Senate Agriculture, Rural Development, FDA and Related Agencies Appropriations Subcommittee for including a $186 million increase for the U.S. Food and Drug Administration (FDA) in its Fiscal Year 2008 appropriations bill.
February 7, 2007

President’s Budget Lacks Funds to Stem ‘Silver Tsunami’

The Alliance for Aging Research today warned that the president’s proposed FY 2008 budget lacks sufficient funding to address the growing burden of age-related chronic diseases.